BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23872659)

  • 21. Metabolism of anabolic steroids and their relevance to drug detection in horseracing.
    Teale P; Houghton E
    Bioanalysis; 2010 Jun; 2(6):1085-107. PubMed ID: 21083210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
    Cherkasov A; Ban F; Santos-Filho O; Thorsteinson N; Fallahi M; Hammond GL
    J Med Chem; 2008 Apr; 51(7):2047-56. PubMed ID: 18330978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anabolic steroids and training.
    Hickson RC; Kurowski TG
    Clin Sports Med; 1986 Jul; 5(3):461-9. PubMed ID: 3521896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
    Thevis M; Schänzer W
    Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
    Yarrow JF; McCoy SC; Borst SE
    Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists.
    Marwah P; Marwah A; Lardy HA; Miyamoto H; Chang C
    Bioorg Med Chem; 2006 Sep; 14(17):5933-47. PubMed ID: 16759873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atom-based 3D-chiral quadratic indices. Part 2: prediction of the corticosteroid-binding globulinbinding affinity of the 31 benchmark steroids data set.
    Castillo-Garit JA; Marrero-Ponce Y; Torrens F
    Bioorg Med Chem; 2006 Apr; 14(7):2398-408. PubMed ID: 16325409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational models for predicting the binding affinities of ligands for the wild-type androgen receptor and a mutated variant associated with human prostate cancer.
    Ai N; DeLisle RK; Yu SJ; Welsh WJ
    Chem Res Toxicol; 2003 Dec; 16(12):1652-60. PubMed ID: 14680380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
    Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid.
    Labrie F; Luu-The V; Calvo E; Martel C; Cloutier J; Gauthier S; Belleau P; Morissette J; Lévesque MH; Labrie C
    J Endocrinol; 2005 Feb; 184(2):427-33. PubMed ID: 15684350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico investigations of anti-androgen activity of polychlorinated biphenyls.
    Li X; Ye L; Wang X; Shi W; Liu H; Qian X; Zhu Y; Yu H
    Chemosphere; 2013 Aug; 92(7):795-802. PubMed ID: 23664479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The systematic structure-activity relationship to predict how flavones bind to human androgen receptor for their antagonistic activity.
    Tamura H; Yoshioka M; Hasegawa M; Hosoda A; Matsugi M; Akamatsu M
    Bioorg Med Chem; 2013 Jun; 21(11):2968-74. PubMed ID: 23611768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
    Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
    Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action.
    Tan RS; Scally MC
    Med Hypotheses; 2009 Jun; 72(6):723-8. PubMed ID: 19231088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of matrices for their use in the rapid screening of anabolic steroids by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Galesio M; Rial-Otero R; Capelo-Martínez JL
    Rapid Commun Mass Spectrom; 2009 Jun; 23(12):1783-91. PubMed ID: 19444857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional quantitative structure--activity relationships for androgen receptor ligands.
    Waller CL; Juma BW; Gray LE; Kelce WR
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):219-27. PubMed ID: 8661347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A photochemical approach to 18-nor-17β-hydroxymethyl-17α-methylandrost-13-ene steroids.
    Laktsevich-Iskryk MV; Rudovich AS; Zhabinskii VN; Khripach VA; Hurski AL
    Steroids; 2020 Jul; 159():108652. PubMed ID: 32360417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.